Spermosens AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2019
Revenue	-	-	-	-	12.49	Upgrade
Revenue Growth (YoY)	-	-	-	-	434.22%	Upgrade
Cost of Revenue	-	-	-	-	8.87	Upgrade
Gross Profit	-	-	-	-	3.63	Upgrade
Selling, General & Admin	3.09	4.06	5.63	7.77	10.33	Upgrade
Research & Development	6.14	5.21	5.27	11.63	-	Upgrade
Other Operating Expenses	-0.03	-0.1	-0.02	-0.34	-0.56	Upgrade
Operating Expenses	9.2	9.16	10.87	19.06	9.78	Upgrade
Operating Income	-9.2	-9.16	-10.87	-19.06	-6.15	Upgrade
Interest Expense	-	-1.04	-1.33	-0.13	-0.27	Upgrade
Interest & Investment Income	0	-	-	-	-	Upgrade
Pretax Income	-9.2	-10.2	-12.2	-19.19	-6.42	Upgrade
Net Income	-9.2	-10.2	-12.2	-19.19	-6.42	Upgrade
Net Income to Common	-9.2	-10.2	-12.2	-19.19	-6.42	Upgrade
Shares Outstanding (Basic)	2,538	188	38	11	9	Upgrade
Shares Outstanding (Diluted)	2,538	188	38	11	9	Upgrade
Shares Change (YoY)	1252.94%	392.48%	231.56%	30.35%	87.61%	Upgrade
EPS (Basic)	-0.00	-0.05	-0.32	-1.67	-0.73	Upgrade
EPS (Diluted)	-0.00	-0.05	-0.32	-1.67	-0.73	Upgrade
Free Cash Flow	-12.35	-7.76	-11.05	-19.04	-5.57	Upgrade
Free Cash Flow Per Share	-0.01	-0.04	-0.29	-1.66	-0.63	Upgrade
Gross Margin	-	-	-	-	29.02%	Upgrade
Operating Margin	-	-	-	-	-49.25%	Upgrade
Profit Margin	-	-	-	-	-51.42%	Upgrade
Free Cash Flow Margin	-	-	-	-	-44.61%	Upgrade
EBITDA	-9.02	-8.98	-10.7	-19	-	Upgrade
D&A For EBITDA	0.18	0.18	0.17	0.06	-	Upgrade
EBIT	-9.2	-9.16	-10.87	-19.06	-6.15	Upgrade
EBIT Margin	-	-	-	-	-49.25%	Upgrade
Revenue as Reported	-	-	-	-	13.06	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.